Real-time enrollment status for this germ cell tumor clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:39 AM UTC
| NCT Number | NCT02582697 |
| Recruiting Status | Recruiting |
| Condition | Germ Cell Tumor |
| Phase | Clinical Trial |
| Target Enrollment | 500 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Sydney |
| Last Updated on CT.gov | June 15, 2025 (Jun 15, 2025) |
As of July 13, 2026: Clinical trial NCT02582697 is currently recruiting participants. This clinical trial study for germ cell tumor is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Sydney. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02582697 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02582697 was last updated Jun 15, 2025 (June 15, 2025). HelloStudys verifies this status automatically.